project_id,id,user_id,name,headline,budget,goal,about_html,permalink,video_embed_url,video_url,category_name,category_id,original_image,thumb_image,small_image,large_image,video_cover_image,progress,pledged,total_contributions,total_contributors,state,mode,state_order,expires_at,zone_expires_at,online_date,zone_online_date,sent_to_analysis_at,is_published,is_expired,open_for_contributions,online_days,remaining_time,elapsed_time,posts_count,address,user,reminder_count,is_owner_or_admin,user_signed_in,in_reminder,total_posts,can_request_transfer,is_admin_role,contributed_by_friends
21206,21206,225659,"MDMA no Consultório / MDMA for PTSD","O Brasil participará da LEGALIZAÇÃO DA 1A TERAPIA PSICODÉLICA NA HISTÓRIA! SÓ FALTA O SEU APOIO!","<p class=""fontsize-large"" style=""text-align: justify;"">A pesquisa está planejada para durar dois anos até as publicações em revistas científicas. Para tanto nosso orçamento real seria de 180.000 reais. Porém, <strong>o Pesquisador Principal</strong><span class=""redactor-invisible-space"" style=""line-height: 1.6em;""><strong> (Dr. Eduardo Schenberg</strong><span class=""redactor-invisible-space""><strong>) se dispõe a trabalhar voluntariamente</strong> caso não haja recursos suficientes para seu salário, <span class=""redactor-invisible-space"">o que reduz os custos para ""apenas"" 100.000 reais.</span></span></span></p><blockquote class=""fontsize-base quote"" style=""margin-left: 160px; text-align: justify;"" rel=""margin-left: 160px; text-align: justify;""><em>The study has an </em><em>estimated duration of two years until publication of peer-reviewed papers. For that our real budget would be 180,000.00 reais (nearly 45,000.00 dollars). <strong>However, our<em> principal investigator (Dr. Eduardo Schenberg) is willing to work voluntarily for this study in case there aren't enough resources available to cover his income.</em></strong><strong> This alone reduces our costs to about 1<em>00,000.00 reais (nearly 26,000.00 dollars)</em></strong><br></em></blockquote><p class=""fontsize-large"" style=""text-align: justify;"">A nossa meta no financiamento coletivo é ainda menor pois quando arrecadarmos o valor mínimo de 50.000 reais, <strong>a MAPS vai doar todo o MDMA que precisamos além de 15 MIL DOLARES para complementar o orçamento do nosso estudo no Brasil.</strong></p><p class=""fontsize-base quote"" style=""margin-left: 160px; text-align: justify;""><em>Our crowdfunding goal is even lower due to the fact that if we raise the 50,000.00 reais (nearly 12,500.00 dollars) <strong>MAPS will donate not only all the MDMA needed for the study but also an aditional 15,000.00 dollars to complement our budget.</strong></em></p><p><strong></strong></p><p style=""text-align: center;""><strong><img src=""https://s3.amazonaws.com/cdn.catarse/uploads/redactor_rails/picture/data/33755/Captura_de_Tela_2015-12-12__s_18.12.29.png"" width=""384"" height=""176"" style=""width: 384px; height: 176px;""></strong></p><p class=""fontsize-large""><br><strong>Distribuição dos Recursos</strong> // <em>Distribution of resources</em><em></em><br></p><p><img src=""https://s3.amazonaws.com/cdn.catarse/uploads/redactor_rails/picture/data/33795/Captura_de_Tela_2015-12-13__s_23.48.59.png"" width=""713"" height=""435"" style=""width: 713px; height: 435px;""></p><p><br></p>
<p style=""text-align: center;""><strong><br></strong></p>",50000.0,"<p class=""fontsize-large"" style=""margin-left: 160px;""><strong>English Speakers,<br>we're counting on your support</strong></p><blockquote class=""fontsize-base quote"" style=""margin-left: 160px; text-align: justify;"">We're also terrebly sorry for the inconvenience. <br>Our description has been translated for you below but this is a Brazilian crowdfunding site, therefore all it's content is in portuguese by default. With the <strong>quick and easy </strong><span class=""redactor-invisible-space"">hacks that follow we hope you can participate in our campaign as well. And for any questions you may have our support team at <strong>contato@catarse.me </strong><span class=""redactor-invisible-space"">is ready and happy to help!<br><br>To quickly translate this page and others, please install one of these free extentions and apps in: <strong><a href=""https://chrome.google.com/webstore/detail/google-translate/aapbdbdomjkkjkaonfhkkikfgjllcleb?hl=en"" target=""_blank"">Chrome</a></strong> | <a href=""https://addons.mozilla.org/en-US/firefox/addon/google-translator-for-firefox/"" target=""_blank""><strong>Firefox</strong></a> | <a href=""https://extensions.apple.com/details/?id=com.sidetree.Translate-S64NDGV2C5"" target=""_blank""><strong>Safari</strong></a> | <strong><a href=""http://www.iegallery.com/en-us/Addons/Details/738"" target=""_blank"">Internet Explorer</a> |</strong> <a href=""https://play.google.com/store/apps/details?id=com.google.android.apps.translate&hl=en"" target=""_blank""><strong>Android</strong></a> | <strong><a href=""https://itunes.apple.com/en/app/google-translate/id414706506?mt=8"" target=""_blank"">Iphone</a></strong></span><br></span></blockquote><p><br></p><p class=""fontsize-larger fontweight-semibold"" style=""text-align: justify;"" rel=""text-align: justify;"">O Brasil fará parte do estudo científico que vai regimentar a psicoterapia psicodélica pela primeira vez na história.<br></p><p class=""fontsize-larger fontweight-semibold"" style=""text-align: justify;"">Arrecadamos nossa meta-base de 50 mil mas temos metas adicionais. Contribuições continuam bem vindas até segunda-feira 21/12 as 23:59!!!</p><p class=""fontsize-larger fontweight-semibold"" style=""text-align: justify;""><br><strong><a href=""https://www.catarse.me/projects/21206/contributions/new?reward_id=61814"">CONTRIBUA!</a></strong></p><p class=""fontsize-base quote"" style=""text-align: justify; margin-left: 160px;""><em>Brazil will take part in the scientific study that will <strong>regulate psychedelic therapy for the first time in history</strong>. We <strong>raised <em><strong>the </strong></em>50.000 reais (</strong></em><em><strong><em>nearly</em> <em>12,500.00</em> dollars) but we have additional goals so please keep donating until December 21, 2015</strong></em>.<br><em><strong><a href=""https://www.catarse.me/projects/21206/contributions/new?reward_id=61814"">PLEASE SUPPORT OUR RESEARCH!</a></strong></em></p><p class=""fontsize-larger fontweight-semibold"" style=""text-align: justify;""><strong>E temos novas recompensas!</strong></p><blockquote class=""fontsize-base quote"" style=""margin-left: 160px;""><strong>And we have new rewards to offer you!</strong></blockquote><p class=""fontsize-large"" style=""text-align: justify;""><strong><a href=""https://www.catarse.me/projects/21206/contributions/new?reward_id=63043"">Apoie com R$150,00 e ganhe um poster A3</a>, doados por artistas da Bienal Internacional de Artes Psicodélicas!</strong></p><blockquote class=""fontsize-base quote"" style=""margin-left: 160px; text-align: justify;""><strong><a href=""https://www.catarse.me/projects/21206/contributions/new?reward_id=63043"">Back our research with US$39.00 and get a poster</a> donated by artists from the International Biennial of Psychedelic Arts!</strong></blockquote><p style=""text-align: center;""><a href=""https://www.catarse.me/projects/21206/contributions/new?reward_id=63043""><img style=""width: 197px; height: 277px;"" src=""https://s3-sa-east-1.amazonaws.com/cdn.br.catarse/uploads/redactor_rails/picture/data/33956/a39.jpg"" alt="""" height=""277"" width=""197""></a>    <a href=""https://www.catarse.me/projects/21206/contributions/new?reward_id=63043""><img style=""width: 205px; height: 277px;"" src=""https://s3-sa-east-1.amazonaws.com/cdn.br.catarse/uploads/redactor_rails/picture/data/33958/a32.jpg"" alt="""" height=""277"" width=""205""></a>    <a href=""https://www.catarse.me/projects/21206/contributions/new?reward_id=63043""><img style=""width: 195px; height: 277px;"" src=""https://s3-sa-east-1.amazonaws.com/cdn.br.catarse/uploads/redactor_rails/picture/data/33961/a31.jpg"" alt="""" height=""277"" width=""195""></a></p><p class=""fontsize-large"" style=""text-align: center;""><strong>Confira todos os posters aqui </strong>// Check all the posters here:<br> <br><a href=""https://www.facebook.com/media/set/?set=a.926099417473221.1073741831.326003940816108&type=3"" target=""_blank"">Arte Psicodélica pela Ciência Visionária<br></a>// Psychedelic Art for Visionary Science<br></p><p style=""text-align: center;""><strong>entrega/retirada a combinar após o fim da campanha<br></strong>// shipping conditions will be determined <span class=""redactor-invisible-space"">after the end of the campaign</span></p><p class=""fontsize-large""><strong><br></strong></p><p class=""fontsize-large""><strong>Saiba mais</strong><em> // Our story</em></p><iframe style=""width: 500px; height: 281px;"" rel=""width: 500px; height: 281px;"" src=""//www.youtube.com/embed/fsnUPHwiV0M"" allowfullscreen="""" frameborder=""0""></iframe><p style=""text-align: justify;"">Nos ultimos 30 anos a <strong><a href=""http://www.maps.org/"" target=""_blank"">Multidisciplinary Association for Psychedelic Studies</a> </strong><span class=""redactor-invisible-space"">(<strong>MAPS</strong>)</span> arrecadou e investiu 23 milhões de dólares em pesquisas científicas com substâncias psicodélicas, incluindo LSD, MDMA, ibogaína e ayahuasca. Suas publicações científicas sobre o tratamento com MDMA em revistas especializadas foram elogiadas inclusive na revista científica mais importante do mundo, a Nature.<br></p><p class=""fontsize-base quote"" style=""margin-left: 160px; text-align: justify;"" rel=""margin-left: 160px; text-align: justify;""><em>In the past 30 years the <a href=""http://www.maps.org/"" target=""_blank"">Multidisciplinary Association for Psychedelic Studies</a> (MAPS) raised and invested 23 million dollars in scientific research with psychedelics, including LSD, MDMA, ibogaine and ayahuasca. Their scientific publications on treatment with MDMA in specialized magazines were praised even in the most important scientific journal in the world, Nature.</em><em></em></p><p style=""text-align: justify;"">O plano da MAPS é a regulamentar a primeira psicoterapia psicodélica no mundo até 2021, com <strong>uso do MDMA para facilitar tratamento de pacientes com Transtorno de Estresse Pós-Traumático</strong> (<strong>TEPT</strong>) grave, crônico e resistente aos medicamentos atuais. Para isso serão investidos cerca de 20 milhões de dólares em um estudo internacional com centenas de pacientes, que vai começar em 2017.</p><p class=""fontsize-base quote"" style=""margin-left: 160px; text-align: justify;""><span class=""redactor-invisible-space"">MAPS plans to regulate the first psychedelic therapy in the world by 2021, using of MDMA to facilitate treatment of patients with severe (PTSD, chronic and resistant to current drugs. For this purpose MAPS will invest about 20 million dollars in an international study of hundreds of patients, which will start in 2017.</span></p><p class=""fontsize-larger fontweight-semibold"" style=""text-align: justify;"" rel=""text-align: justify;"">Ao final teremos regimentado não só a primeira terapia psicodélica do mundo, mas o primeiro medicamento da história feito por entidades sem fins lucrativos.</p><p class=""fontsize-base quote"" style=""margin-left: 160px; text-align: justify;""><em>At the end of it we'll have regulated not only the first psychedelic therapy in the world, but</em><em> <strong>the first drug in history made by a non-profit entities.<br></strong></em></p><p style=""text-align: justify;"">A fase 3 do estudo clínico da MAPS acontecerá <span class=""redactor-invisible-space"">em 2017. <strong><span class=""redactor-invisible-space"">Essa é a última etapa na sequência de pesquisa que leva à regulamentação de um medicamento farmacêutico. </span></strong>Depois disso o medicamento pode ser comercializado legalmente. Já participam da pesquisa <span class=""redactor-invisible-space"" style=""line-height: 1.6em;"">países como</span> EUA, Canadá, Suíça e Israel. <strong>O Brasil pode entrar nessa lista! Mas, </strong><strong>precisamos primeiro fazer em 2016 um estudo piloto (um pequeno ensaio com quatro pacientes).</strong></span></p><p class=""fontsize-base quote"" style=""margin-left: 160px; text-align: justify;""><em>MAPS's phase 3</em><em> clinical trial will take place in 2017. <strong>This is the last stage in the sequence of research that leads to the regulation of a pharmaceutical drug</strong>. <em>After that phase a product may be legally marketed. Countries like USA, Canada, Switzerland and Israel are already participating in the study. <strong>Brazil can be included in this list!</strong></em><strong> But first we must execute a pilot study in 2016 (a small trial with only four patients).</strong></em></p><p style=""text-align: center;""><em><strong><img src=""https://s3.amazonaws.com/cdn.catarse/uploads/redactor_rails/picture/data/33733/Captura_de_Tela_2015-12-12__s_18.12.16.png""></strong></em></p><p style=""text-align: justify;""><strong>Já temos aprovação da </strong><a href=""http://conselho.saude.gov.br/Web_comissoes/conep/index.html"" target=""_blank""><strong>Comissão Nacional de Ética em Pesquisa</strong></a> <strong>(CONEP) para realizar o estudo piloto (fase 2) em 2016 </strong>(CAAE 46252015.2.0000.5511). Se nossa arrecadação aqui no Catarse for bem sucedida, poderemos nos juntar ao <strong>estudo multicêntrico internacional (fase 3) em 2017.</strong></p><p class=""fontsize-base quote"" style=""margin-left: 160px; text-align: justify;""><em><em><strong>We already have Government approval from <a href=""http://conselho.saude.gov.br/Web_comissoes/conep/index.html"" target=""_blank"">CONEP</a> </strong>(the Ministry of Health group that regulates and oversees clinical trials in Brazil) <strong>to execute the<em><em> pilot study in 2016</em></em>. </strong>If we succeed with our fundraiser now we'll be able <em>to then join MAPS in its international study in 2017</em><span class=""redactor-invisible-space"">.</span></em><br></em></p><p style=""text-align: center;"" rel=""text-align: center;""><em><em><span class=""redactor-invisible-space""><img src=""https://s3.amazonaws.com/cdn.catarse/uploads/redactor_rails/picture/data/33753/Captura_de_Tela_2015-12-12__s_23.19.03.png""><br></span></em></em></p><p style=""text-align: center;""><em><em><span class=""redactor-invisible-space""><br></span></em></em></p><p class=""fontsize-larger fontweight-semibold"" style=""text-align: center;"" rel=""text-align: center;"">SÓ FALTA O SEU APOIO, <strong><a href=""https://www.catarse.me/projects/21206/contributions/new?reward_id=61814"">COLABORE!</a></strong><strong></strong></p><p class=""fontsize-large"" style=""text-align: center;""><em>ALL WE NEED IS YOUR SUPPORT, <strong><a href=""https://www.catarse.me/projects/21206/contributions/new?reward_id=61814"">BACK OUR RESEARCH!</a></strong></em></p><p><br></p><p class=""fontsize-large""><strong>Quem somos?</strong><em> // About us</em></p><p><img style=""float: left; width: 146px; height: 165px; margin: 0px 10px 10px 0px;"" alt="""" src=""https://s3.amazonaws.com/cdn.catarse/uploads/redactor_rails/picture/data/28725/logo_plantando280px_texto.jpg.png"" height=""165"" width=""146""></p><p style=""text-align: justify;"">Este projeto é mais uma iniciativa inovadora do <strong><a href=""http://www.plantandoconsciencia.org/"" target=""_blank"">Plantando Consciência, uma organização sem fins lucrativos</a> </strong>registrada como Organização da Sociedade Civil de Interesse Publico (OSCIP) em 2011 e dedicada ao estudo dos estados não-ordinários de consciência desde 2009. Em poucos anos de existência já confirmamos nosso pioneirismo no estudo neurofisiológico da ayahuasca, no potencial da ayahuasca no tratamento do câncer e na pesquisa sobre o uso terapêutico da ibogaína no tratamento da dependência química.</p><p class=""fontsize-base quote"" style=""margin-left: 160px; text-align: justify;""><em>This project is one more innovative action of <strong><a href=""http://www.plantandoconsciencia.org/"" target=""_blank"">Plantando Consciencia, a non-profit organization</a>, </strong>registered in 2011 in Brazil as an ""Organization of the Civil Society of Public Interest (OSCIP)"". Since 2009 we are <strong>dedicated to the study of non-ordinary states of consciousness</strong>. In just a few years we have pioneered scientific papers about the use of ayahuasca in treatment of cancer, in the study of neurophysiological mechanisms of ayahuasca and in research about ibogaine in the treatment of addiction.<br></em></p><p><img style=""float: left; width: 162px; height: 160px; margin: 0px 10px 10px 0px;"" alt="""" src=""https://s3.amazonaws.com/cdn.catarse/uploads/redactor_rails/picture/data/28740/eu_juquehy_280_px.png"" height=""160"" width=""162""></p><p style=""text-align: justify;""><em>Estes estudos, liderados pelo <strong><a href=""https://www.researchgate.net/profile/Eduardo_Schenberg"" target=""_blank"">Dr. Eduardo Schenberg, Neurocientista e Diretor do Plantando Consciência,</a></strong> foram publicados em revistas científicas de prestígio internacional em 2013, 2014 e 2015. Neste período também <strong>participou da primeira pesquisa de neuroimagem com LSD no Imperial College London.</strong><strong> É o responsável pelo projeto de tratamento do TEPT com MDMA,</strong> já aprovado pela Comissão Nacional de Ética em Pesquisa (CONEP) e portanto habilitado para início no Brasil.</em></p><p class=""fontsize-base quote"" style=""margin-left: 160px; text-align: justify;""><em>These studies, headed by <strong><a href=""https://www.researchgate.net/profile/Eduardo_Schenberg"" target=""_blank"">Eduardo Schenberg, PhD in neuroscience and Plantando Consciência's Director</a></strong> we</em><em>re published in peer-reviewed papers in 2013, 2014 and 2015. In this period <strong>Eduardo also participated in the world's first neuroimagen research with LSD in humans at Imperial College London. He is responsible for the MDMA-assisted psychotherapy for PTSD project</strong> already approved in Brazil by Comissão Nacional de Ética em Pesquisa (CONEP) and therefore ready to start.<br></em></p><p><img style=""float: left; width: 205px; height: 138px; margin: 0px 10px 10px 0px;"" alt="""" src=""https://s3.amazonaws.com/cdn.catarse/uploads/redactor_rails/picture/data/31669/alvaro_dora.jpg"" height=""138"" width=""205""></p><p style=""text-align: justify;""><strong>Par</strong><strong>a a psicoter</strong><strong>apia contamos com o casal </strong><a href=""http://www.aljardim.com.br/equipe.php""><strong>Álvaro e Dora Jardim, com mais de 30 anos de experiência clínica</strong></a><strong>.</strong> Eles trabalham com o potencial curativo dos estados não ordinários de consciência e<strong> foram treinados pelo maior especialista sobre psicodélicos do mundo, o psiquiatra Tcheco Stanislav Grof, 20 anos atrás</strong>. Desde então se dedicam com afinco à prática e ensino da Respiração Holotrópica, técnica de autoexploração e terapia desenvolvida por Grof e também praticada pelos terapeutas da MAPS. Eles já atenderam centenas de pacientes com TEPT usando a Respiração Holotrópica e estão preparados para aplicar a terapia com MDMA.</p><p class=""fontsize-base quote"" style=""margin-left: 160px; text-align: justify;""><strong>For the psychotherapy we count on </strong><strong><a href=""http://www.aljardim.com.br/equipe.php"" target=""_blank"">Álvaro and Dora Jardim, who have more than 30 years of clinical practice</a></strong>. They work with the therapeutic potential of non-ordinary states of consciousness, and <strong>were trained by the world's foremost expert in psychedelics, Czech psychiatrist Stanislav Grof, 20 years ago</strong>. Since then they are dedicated to the teaching and practice of Holotropic Breathwork, a technique for self-exploration and healing developed by Grof and also practiced by MAPS's therapists. They treated hundreds of PTSD patients using Holotropic Breathwork and are ready to employ MDMA-assisted psychotherapy.<br></p><p><img style=""float: left; width: 148px; height: 147px; margin: 0px 10px 10px 0px;"" src=""https://s3.amazonaws.com/cdn.catarse/uploads/redactor_rails/picture/data/33738/Captura_de_Tela_2015-12-12__s_17.53.19.png"" alt="""" height=""147"" width=""148""></p><p style=""text-align: justify;""><strong>Para a admi</strong><strong>nistração do MDMA e para garantir a segurança dos pacientes durante todo o processo</strong>, contamos ainda com o trabalho do <strong>Dr. Bruno Rasmussen Chaves</strong>, <strong>médico. </strong>Ele tem mais de 10 anos de experiência no uso da ibogaína no tratamento da dependência química, e portanto também muito capacitado para lidar com estados não-ordinários de consciência de forma terapêutica e responsável.</p><p class=""fontsize-base quote"" style=""margin-left: 160px; text-align: justify;""><em><strong>For the MDMA administration and to ensure patient's safety</strong>, we count on the expertise of <strong>Dr. Bruno Rasmussen Chaves, MD</strong>. He has more than 10 years of experience with ibogaine in the treatment of substance use disorders and is therefore very well trained to deal with non-ordinary states of consciousness in a therapeutic and responsible manner.<br></em></p><p><img style=""float: left; width: 359px; height: 98px; margin: 0px 10px 10px 0px;"" alt="""" src=""https://s3.amazonaws.com/cdn.catarse/uploads/redactor_rails/picture/data/29836/dartiu_tof_sid_280px2.png"" height=""98"" width=""359""></p><p style=""text-align: justify;"">A equipe de pesquisa conta ainda com <strong>participação de três pesquisadores e docentes<strong> de Universidades de ponta no Brasil</strong> </strong>e destacada produção científica. Da esquerda para direita: <em><strong>Dartiu Xavier da Silveira</strong>, da UNIFESP, </em><em><strong>Luís Fernando Tófoli,</strong> da UNICAMP e </em><em><strong>Sidarta Ribeiro</strong>, da UFRN.</em></p><p class=""fontsize-base quote"" style=""margin-left: 160px; text-align: justify;""><em><em>The research </em><em>team also includes <strong>three prominent professors in Brazil</strong>. From left to right: </em><strong>Dartiu Xavier da Silveira</strong>, from UNIFESP, </em><em><strong>Luis Fernando Tófoli</strong>, at UNICAMP and </em><em><strong>Sidarta Ribeiro, from UFRN</strong>.<br></em></p><p><img style=""float: left; width: 175px; height: 135px; margin: 0px 10px 10px 0px;"" src=""https://s3.amazonaws.com/cdn.catarse/uploads/redactor_rails/picture/data/33754/Captura_de_Tela_2015-12-13__s_03.51.03.png"" alt="""" height=""135"" width=""175""></p><p style=""text-align: justify;"">E por fim temos nosso <strong>advogado, Cristiano Maronna, Mestre e Doutor em Direito Penal pela USP</strong>, secretário-executivo da <strong>Plataforma Brasileira de Política de Drogas (PBPD)</strong> que nos auxilia com as questões jurídicas envolvidas em todo o processo</p><p class=""fontsize-base quote"" style=""margin-left: 160px; text-align: justify;"">And finally, we have <strong>our lawyer, Cristiano Maronna,</strong> who holds a <strong>doctorate in Penal Law from University of São Paulo</strong>, executive-secretary of the ""<strong>Brazilian Platform for Drug Policy (PBPD)</strong>"", helping us with all legal issues related to this project.</p><p><strong><br></strong></p><p class=""fontsize-large""><strong>Por que financiamento coletivo? </strong><em>// Why</em> crowdfunding?<br><em></em></p><p style=""text-align: justify;"">Com a crise o financiamento de pesquisas científicas não foi considerado prioridade no orçamento do Governo Federal este ano, nem parece que será em 2016. <strong>Como temos urgência em fazer a primeira pesquisa em 2016 para nos juntarmos ao estudo internacional em 2017, não podemos esperar!</strong> Ademais, o financiamento coletivo é muito apropriado para o estudo de uma substância com enormes potenciais terapêuticos, mas cuja pesquisa é desestimulada por moralismos e ideologias governamentais.</p><p class=""fontsize-base quote"" style=""margin-left: 160px; text-align: justify;""><em>Brazil is currently going through a deep crisis in Federal Funding for science, and that doesn't seem to going away any time soon. <strong>As we have urgency to make the pilot study to follow up to the international study in 2017, we can not wait! </strong>Furthermore, crowdfunding is a very appropriate alternative for the study of a substance with enormous therapeutic potentials but that is still misjudged <em>by the government </em>on the basis of morality and ideology.</em></p><p class=""fontsize-large""><strong>Riscos e desafios </strong><em>// Risks and challenges</em></p><p style=""text-align: justify;"">Quando arrecadarmos os 50.000 reais aqui no Catarse, a MAPS vai doar o MDMA para o estudo brasileiro, sem custo algum. O principal risco envolvido nesta campanha se relaciona com a importação da substância. <strong>Já estamos trabalhando em um pedido de Autorização Especial Simplificada para estabelecimentos de Ensino e Pesquisa (AEP) junto à <a href=""http://portal.anvisa.gov.br/wps/portal/anvisa/home"" target=""_blank"">Agência Nacional de Vigilância Sanitária (ANVISA)</a></strong>. Na hipótese remota de que o nosso pedido seja recusado, impedindo assim a realização da pesquisa, todos os recursos obtidos serão redirecionados a uma campanha educativa e, <strong>se necessário for, levaremos essa discussão ao Judiciário</strong>. Já é hora de reclassificar os psicodélicos no Brasil, permitindo assim seu uso em pesquisas científicas e desenvolvimentos de novas formas terapêuticas embasadas em evidências científicas sólidas.</p><p class=""fontsize-base quote"" style=""margin-left: 160px; text-align: justify;""><em>Once we reach our fundraising goal here at Catarse, MAPS will donate the MDMA for the Brazilian study at no cost. The main risk involved in this campaign relates to the importation of the substance. <strong>We are already working on an application for a Special Simplified Authorization for Education and Research establishments to be granted by the <a href=""http://portal.anvisa.gov.br/wps/portal/anvisa/home"" target=""_blank"">National Health Surveillance Agency (ANVISA)</a></strong>, that regulates these substances in Brazil. </em><em>In the unlikely event that our request down, thus preventing the research, all the proceeds will be redirected to an educational campaign and, <strong>if necessary, we will take this discussion to the judiciary</strong>. It's time to reclassify psychedelics in Brazil, allowing their use in scientific research and development of new therapeutic ways informed on solid scientific evidence.</em></p><p class=""fontsize-large""><strong>Principais referências científicas</strong> <em>// Main scientific reference</em></p><p style=""text-align: justify;"">Segurança e eficácia da psicoterapia assistida com 3,4-metilenodioximetanfetamina em sujeitos com transtorno do estresse pós-traumático crônico e resistente à tratamento: o primeiro estudo piloto controlado e randomizado. <a target=""_blank"" href=""http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3122379/"">Journal of Psychopharmacology, 2011</a><em>.</em></p><blockquote class=""fontsize-base quote"" style=""text-align: justify; margin-left: 160px;""><em>The safety and efficacy of 3,4-methylenedioxymethamphetamine-assisted psychotherapy in subjects with chronic, treatment-resistant post-traumatic stress disorder: the first randomized controlled pilot study. <a target=""_blank"" href=""http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3122379/"">Journal of Psychopharmacology, 2011</a></em><em>.</em></blockquote><p style=""text-align: justify;"">Durabilidade da melhora nos sintomas de estresse pós-traumático e ausência de efeitos danosos ou dependência química após psicoterapia assistida com 3,4-metilenodioximetanfetamina: um estudo prospectivo de longo prazo. <span class=""redactor-invisible-space"" style=""line-height: 1.6em;""><a target=""_blank"" href=""http://jop.sagepub.com/content/early/2012/08/29/0269881112456611.long"">Journal of Psychopharmacology, 2012</a>.</span></p><blockquote class=""fontsize-base quote"" style=""margin-left: 160px; text-align: justify;""><span class=""redactor-invisible-space"" style=""line-height: 1.6em;""></span><em>Durability of improvement in posttraumatic stress disorder symptoms and absence of harmful effects or drug dependency after 3,4-methylenedioxymethamphetamine-assisted psychotherapy</em><span class=""redactor-invisible-space"" style=""line-height: 1.6em; background-color: initial;""><em>: a prospective long-term follow-up study. </em><span class=""redactor-invisible-space"" style=""line-height: 1.6em; background-color: initial;""><em><a target=""_blank"" href=""http://jop.sagepub.com/content/early/2012/08/29/0269881112456611.long"">Journal of Psychopharmacology, 2012</a>.</em></span></span></blockquote><p style=""text-align: justify;""><span class=""redactor-invisible-space"" style=""line-height: 1.6em;"">MDMA mantém o estresse severo à distância. <a target=""_blank"" href=""http://www.nature.com/news/mdma-keeps-severe-stress-at-bay-1.11864"">Nature, 2012</a>.</span></p><blockquote class=""fontsize-base quote"" style=""margin-left: 160px; text-align: justify;""><span class=""redactor-invisible-space"" style=""line-height: 1.6em;""></span><em>MDMA keeps severe stress at bay. <a target=""_blank"" href=""http://www.nature.com/news/mdma-keeps-severe-stress-at-bay-1.11864"">Nature, 2012</a></em><em>.</em></blockquote><p style=""text-align: justify;""><span class=""redactor-invisible-space"" style=""line-height: 1.6em;"">O impacto da violência epidêmica na prevalência de desordens psiquiátricas em São Paulo e no Rio de Janeiro. <a target=""_blank"" href=""http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0063545"">PLOS ONE, 2013.</a></span></p><blockquote class=""fontsize-base quote"" style=""margin-left: 160px; text-align: justify;""><span class=""redactor-invisible-space"" style=""line-height: 1.6em;""><a target=""_blank"" href=""http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0063545""></a></span>The impact of epidemic violence on the prevalence of psychiatric disorders in Sao Paulo and Rio de Janeiro, Brazil. <a target=""_blank"" href=""http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0063545"">PLOS ONE, 2013.</a></blockquote><p style=""text-align: justify;""><span class=""redactor-invisible-space"" style=""line-height: 1.6em;"">Transformando o MDMA em remédio. <a target=""_blank"" href=""http://bjp.rcpsych.org/content/206/1/4"">British Journal of Psychiatry, 2015</a></span></p><blockquote class=""fontsize-base quote"" style=""margin-left: 160px; text-align: justify;""><span class=""redactor-invisible-space"" style=""line-height: 1.6em;""><a target=""_blank"" href=""http://bjp.rcpsych.org/content/206/1/4""></a></span>Making a medicine out of MDMA. <a target=""_blank"" href=""http://bjp.rcpsych.org/content/206/1/4"">British Journal of Psychiatry, 2015</a>.<span></span></blockquote><p><em></em></p><p><a target=""_blank"" href=""http://bjp.rcpsych.org/content/206/1/4""></a></p>",MDMA,//www.youtube.com/embed/NKsO6uOW2Hk,https://youtu.be/NKsO6uOW2Hk,"Ciência e Tecnologia",18,https://s3-sa-east-1.amazonaws.com/cdn.br.catarse/uploads/project/uploaded_image/21206/novo_card_projeto.png,https://s3-sa-east-1.amazonaws.com/cdn.br.catarse/uploads/project/uploaded_image/21206/project_thumb_thumb_novo_card_projeto.png,https://s3-sa-east-1.amazonaws.com/cdn.br.catarse/uploads/project/uploaded_image/21206/project_thumb_small_novo_card_projeto.png,https://s3-sa-east-1.amazonaws.com/cdn.br.catarse/uploads/project/uploaded_image/21206/project_thumb_large_novo_card_projeto.png,https://s3-sa-east-1.amazonaws.com/cdn.br.catarse/uploads/project/uploaded_image/21206/project_thumb_video_cover_novo_card_projeto.png,106.68000000000000000000,53340.0,419,407,successful,aon,finished,"2015-12-22 01:59:59.999999","2015-12-21 23:59:59.999999","2015-11-10 09:28:47.065354","2015-11-10 07:28:47.065354",,t,t,f,41,"{""total"" : 0, ""unit"" : ""seconds""}","{""total"" : 41, ""unit"" : ""days""}",10,"{""city"" : ""São Paulo"", ""state_acronym"" : ""SP"", ""state"" : ""São Paulo""}","{""id"" : 225659, ""name"" : ""Plantando Consciência""}",29,,f,f,290,f,f,f